Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds

Detailed price information for Kiora Pharmaceuticals Inc. (KPRX-Q) from The Globe and Mail including charting and trades.
News-Medical.Net

Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR

Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Pharmabiz

India gains ground in excipients globally as manufacturers add capacity, improve compliance: Amit Raj Sinha

India gains ground in excipients globally as manufacturers add capacity, improve compliance: Amit Raj Sinha: Shardul Nautiyal, Mumbai Wednesday, December 24, 2025, 08:00 Hrs [IST] ...

SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Gastric Cancer.

SNB-101 previously received ODDs from the US FDA for small cell lung cancer in July 2023 and pancreatic cancer in February 2024. By receiving an ODD for gastric cancer this time, SN Bioscience expects ...

NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
Clinical Trials Arena on MSN

Psyence gains HREC nod to use PsyLabs’ psilocybin in adjustment disorder trial

With several sites activated and recruitment ongoing, the Phase IIb trial is projected to deliver top-line outcomes next year ...